Page 48 - P4304.1-V96_PS-Magazine-April 2024

Benefit from our great terms for

Dispensing Doctors with...
AgaMatrix

WaveSense JAZZ™ offers PSUK is pleased to offer a 40% discount

the Lowest Net Price and on Sereflo pMDIs for dispensing practices

Highest Profit compared to NEW

these other sub £10 strips WaveSense JAZZ™
WIRELESS meter
now available Product NHS List price 1 PSUK discount Saving
Uses the same strip as the
WaveSense JAZZ™ blood
glucose meter Sereflo pMDI £14.99 40% £5.99
25/125mcg

Sereflo pMDI 40% £7.99
25/250mcg £19.99

Sereflo pMDI can offer a 25mcg salmeterol with 125 or 250mcg fluticasone
Blood Glucose Testing Strips combination more cost-effectively than the market-leading competitors,
BY BRAND
1-3
Seretide® and Sirdupla® (salmeterol/fluticasone). Plus, you can take
advantage of significant additional savings with the PSUK discount.
NHS Profit Per
Supplier Product Description PIP Code Rebate WD Nett Price
Price Pack
AgaMatrix WaveSense JAZZ™ Test Strips (50) 3401619 £8.74 24% 5% £6.21 £2.53
Sereflo pMDI is indicated for use in adults with asthma 18 years of age and older only. 4,5
AgaMatrix WaveSense JAZZ™ DUO Test Strips (2 x 25) 3725553 £8.74 24% 5% £6.21 £2.53 Sereflo pMDI is indicated in the regular treatment of patients with moderate to severe asthma
AgaMatrix Agile Test Strips (50) 4254355 £5.99 13% 5% £4.91 £1.08 where use of a combination product (long-acting β2 agonist and inhaled corticosteroid)
is appropriate:
- patients not adequately controlled on a lower strength corticosteroid combination product 4,5
GlucoRX GlucoRx Nexus Test Strips (50) - £8.95 0% 3% £8.68 £0.27
or
GlucoRX GlucoRx HCT Test Strips (50) - £8.95 0% 3% £8.68 £0.27 - patients already adequately controlled on an inhaled corticosteroid in a mid or
high strength and a long-acting β2 agonist. 4,5
GlucoRX GlucoRx Q Test Strips (50) - £5.45 0% 3% £5.19 £0.26
Seretide is a trademark of GSK. Sirdupla is a registered trademark of Mylan.
pMDI = pressurised metered dose inhaler.
Spirit Healthcare TEE2 Test Strips (50) - £7.75 0% 12% £6.82 £0.93
Spirit Healthcare Caresens N Test Strips (50) - £12.75 0% 0% £12.75 £0.00 Sereflo Metered Dose Inhaler (salmeterol xinafoate/fluticasone with caution in patients with severe cardiovascular disorders or heart rhythm abnormalities and in
®
propionate) patients with diabetes mellitus, thyrotoxicosis, uncorrected hypokalaemia or with a predisposition to
Spirit Healthcare Caresens Pro Test Strips (50) - £9.95 0% 12% £8.76 £1.19 Prescribing Information low levels of serum potassium. Prescribers should also be aware of the risk of adrenal suppression
Please consult the full Summary of Product Characteristics (SmPC) before prescribing and acute adrenal crisis which may occur in patients on prolonged treatment with high doses of
inhaled corticosteroids. Systemic effects may occur with any inhaled corticosteroid and it is important
Sereflo 25 microgram (μg) salmeterol xinafoate /125 μg or 250 μg fluticasone propionate per actuation therefore, that the patient is reviewed regularly and the dose of inhaled corticosteroid is reduced to the
Ypsomed Mylife Pura Test Strips (50) - £9.50 0% 12% £8.36 £1.14 pressurised inhalation, suspension. For both dose strengths the equivalent delivered dose per lowest dose at which effective control of asthma is maintained. Visual disturbances may be reported
actuation is 21 μg of salmeterol and the delivered fluticasone propionate is 110 μg, for 125 μg dose
strength and 220 μg, for 250 μg dose strength. INDICATIONS: For use in adults with asthma 18 years with steroid use. Patients presenting with blurred vision or other visual disturbances should be
Ypsomed Mylife Unio Test Strips (50) - £9.50 0% 12% £8.36 £1.14 of age and older only. Sereflo is indicated in the regular treatment of patients with moderate to severe considered for referral to an ophthalmologist. Drug Interactions: Concomitant use should be avoided
asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is with; non-selective and selective β blockers, ritonavir and other potent/moderate CYP3A inhibitors,
appropriate: patients not adequately controlled on a lower strength corticosteroid combination product unless potential benefit outweighs the risk. Particular caution is advised in acute severe asthma
Ypsomed Mylife Aveo Test Strips (50) - £6.95 0% 12% £6.12 £0.83 or patients already adequately controlled on an inhaled corticosteroid in a mid or high strength and as hypokalaemia may be potentiated by concomitant treatment with xanthine derivatives, steroids
a long-acting β2 agonist. POSOLOGY AND ADMINISTRATION: Patients should be instructed and diuretics. See the SmPC for further information on contraindications and precautions.
in the proper use of their inhaler (see SmPC and patient information leaflet). Recommended PREGNANCY AND LACTATION: Balance risks against benefits. UNDESIRABLE EFFECTS:
Nipro Diagnostics 4Sure Test Strips (50) - £8.99 0% 8.25% £8.25 £0.74 doses in adults 18 years and older - Two inhalations of 25μg salmeterol and 125 μg or 250 μg Adverse events which have been associated with salmeterol/fluticasone propionate include: Very
fluticasone propionate twice daily. A short-term trial of salmeterol and fluticasone propionate may be common; nasopharyngitis and headache; Common; candidiasis of the mouth and throat, pneumonia,
considered as initial maintenance therapy in adults with moderate persistent asthma for whom rapid bronchitis, hypokalaemia, throat irritation, hoarseness/dysphonia, sinusitis, contusions, muscle
Menarini Diagnostics GlucoMen Areo Test Strips (50) - £7.25 0% 10% £6.53 £0.72 control of asthma is essential. In these cases, the recommended initial dose is two inhalations of 25 cramps, traumatic fractures, arthralgia and myalgia. For other adverse events please consult the full
μg salmeterol and 50 μg fluticasone propionate twice daily. Note: Sereflo is not available in a lower SmPC. MARKETING AUTHORISATION HOLDER & PL NUMBERS: Cipla (EU) Ltd. Dixcart House,
strength product containing salmeterol 25 μg and fluticasone propionate 50 μg. Therefore, when Addlestone Road, Bourne Business Park, Addlestone, Surrey KT15 2LE. PL 36390/0237 and PL
Menarini Diagnostics GlucoFix Tech Sensors (50) - £5.95 0% 10% £5.36 £0.59 initiating therapy, or when it is appropriate to titrate down to a dose below 125 μg, an alternative 36390/0238. Legal category: POM. NHS Cost 25 μg/125 μg 1x 120 dose MDI £14.99 and 25 μg/250
fixed-dose combination of salmeterol and fluticasone propionate containing a lower dose of the μg 1x 120 doses MDI £19.99. Date of last revision: April 2020.
inhaled corticosteroid is required. Use of a spacer device; where required in those with difficulties in
coordinating actuation of the inhaler with inspiration of breath, it is recommended ONLY for higher
strength Sereflo containing salmeterol 25 μg and fluticasone propionate 250 μg. Patients should Adverse events should be reported. Reporting forms and information can
Sign up now continue to use the same make of spacer device (Volumatic or the AeroChamber Plus) as switching be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard
between spacer devices can result in changes in the dose delivered to the lungs. See the SmPC
reducing to receive the discount at: for further information on initiation, titration down and spacer use. CONTRAINDICATIONS: in the Google Play or Apple App Store. Adverse events should also be
Hypersensitivity to the active substances or to any of the excipients. SPECIAL WARNINGS AND
reported Cipla (EU) Ltd on 0800 0472144, drugsafety@cipla.com
costs... Using WaveSense JAZZ™ PRECAUTIONS: Sereflo should not be used to treat acute asthma symptoms for which a fast- and
short-acting bronchodilator is required. Patients should be advised to have their inhaler to be used
increasing instead of these strips will for relief in an acute asthma attack available at all times. Patients should not be initiated on Sereflo References.
income or ring our dispensing support team during an exacerbation, or significantly worsening or acutely deteriorating asthma. Serious asthma- 1. Dictionary of medicines and devices (dm+d), available at https://www.nhsbsa.nhs.uk/pharmacies-gp-
practices-and-appliance-contractors/dictionary-medicines-and-devices-dmd (accessed August 2022).
related adverse events and exacerbations may occur with Sereflo. Patients should be asked to
increase your practice income 01904 558 350 continue treatment but to seek medical advice if asthma symptoms remain uncontrolled or worsen 2. British National Formulary, Medicinal forms, available at
https://bnf.nice.org.uk/medicinal-forms/fluticasone-with-salmeterol.html (accessed August 2022).
after initiation. Treatment should not be stopped abruptly due to risk of exacerbation. Therapy should
be down-titrated under physician supervision. All inhaled medication containing corticosteroids
4. Sereflo 25 microgram/125 microgram. Summary of Product Characteristics.
should be administered with caution in patients with active or quiescent pulmonary tuberculosis and 3. MIMS.co.uk (accessed August 2022).
48 PS Magazine | MDS Terms Information Buy direct online at PSUK.co.uk fungal, viral or other infections of the airway. Salmeterol and fluticasone propionate should be used 5. Sereflo 25 microgram/250 microgram. Summary of Product Characteristics.
August 2022 CIPSER20220021